Weathering the storm: COVID-19 infection in patients with hematological malignancies / 浙江大学学报(英文版)(B辑:生物医学和生物技术)
Journal of Zhejiang University. Science. B
;
(12): 921-939, 2020.
Article
in English
| WPRIM
| ID: wpr-880734
ABSTRACT
The coronavirus disease 2019 (COVID-19) is an emerging infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Within a matter of months, this highly contagious novel virus has led to a global outbreak and is still spreading rapidly across continents. In patients with COVID-19, underlying chronic diseases and comorbidities are associated with dismal treatment outcomes. Owing to their immunosuppressive status, patients with hematological malignancies (HMs) are at an increased risk of infection and have a worse prognosis than patients without HMs. Accordingly, intensive attention should be paid to this cohort. In this review, we summarize and analyze specific clinical manifestations for patients with coexisting COVID-19 and HMs. Furthermore, we briefly describe customized management strategies and interventions for this susceptible cohort. This review is intended to guide clinical practice.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Risk Factors
/
Immunocompromised Host
/
Hematologic Neoplasms
/
Disease Management
/
Diagnosis, Differential
/
COVID-19
/
Hospitalization
Type of study:
Diagnostic study
/
Etiology study
/
Prognostic study
/
Risk factors
Limits:
Humans
Language:
English
Journal:
Journal of Zhejiang University. Science. B
Year:
2020
Type:
Article
Similar
MEDLINE
...
LILACS
LIS